Stentys SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Stentys SA Self-Apposing Stent Continues To Demonstrate Low Mortality At One Year In Apposition III Trial
Stentys SA announced the interim results of the APPOSITION III clinical trial for the first 600 patients at one year post treatment of a severe heart attack. The APPOSITION III trial was designed to assess the long term performance of STENTYS Self-Apposing Stents in routine clinical practice in 1,000 patients suffering from ST-elevation myocardial infarction (STEMI) in Europe. The interim analysis was conducted on the first 600 patients at the one-year time point and showed a death rate of 1.7% where conventional stents average 3.9% (pooled analysis from ACTION Study Group, Prof. G. Montalescot at Pitié-Salpêtrière Hospital), thus maintaining the early clinical gain that was reported in May 2012 for the one-month time point. The data will be featured at the Transcatheter Cardiovascular Therapeutics (TCT) conference in Miami during a presentation entitled "Primary PCI for STEMI: Drugs, Devices, and Technique Controversies," by Prof. Mudra on October 25, 2012., as well as a satellite symposium chaired by Maurice Buchbinder, M.D., of the Foundation of Cardiovascular Medicine (San Diego), scheduled for October 24, 2012 from 12:15 p.m. to 1:15 p.m. In its latest guidelines on AMI treatment, the European Society of Cardiology (ESC) calls attention to the importance of selecting the appropriate stent size.
Latest Developments for Stentys SA
- Stentys SA Announces Positive Results of Its OPEN II study of Self-Apposing Stent
- Stentys SA Sirolimus-Eluting Stent Demonstrates Faster Arterial Healing Than Conventional Drug-Eluting Stent
- Stentys SA Receives Approval to Expand CE Mark Indications of Its Self-Apposing Stent-DJ
- Stentys SA Announces Positive Interim Results of APPOSITION III Clinical Trial of STENTYS Self-Apposing Stents
Latest Key Developments in Medical
- Share this
- Digg this